Trial Profile
Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted With Cobicistat in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jan 2022
Price :
$35
*
At a glance
- Drugs Cobicistat/darunavir (Primary) ; Dolutegravir (Primary) ; Diphenhydramine; Ibuprofen; Isoniazid; Loperamide; Naproxen; Paracetamol; Pyridoxine; Rifapentine
- Indications HIV infections; HIV-1 infections
- Focus Pharmacokinetics
- 18 Aug 2021 Status changed from recruiting to completed.
- 13 Jan 2021 Planned End Date changed from 31 Dec 2020 to 31 Dec 2021.
- 13 Jan 2021 Planned primary completion date changed from 31 Dec 2020 to 31 Dec 2021.